Lacidipine attenuates TNF-α-induced cardiomyocyte apoptosis

Cytokine

Volumn 71, Issue 1, 2015, Pages 60-65

  Wang, Qiu Lin ^a   Zhao, Lei ^b   Feng, Na ^b   Zhou, Peng ^a   Wu, Qi ^a   Fan, Rong ^b   Li, Juan ^b   Zhang, Shu Miao ^b   Wang, Yue Min ^b   Xu, Xue Zeng ^c   Yu, Shi Qiang ^c   Yi, Ding Hua ^c   Pei, Jian Ming ^b,c  

^a CHENGDU MEDICAL COLLEGE   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 12; Lacidipine; TNF

Indexed keywords

CASPASE 12; CASPASE 3; CASPASE INHIBITOR; LACIDIPINE; TUMOR NECROSIS FACTOR ALPHA; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; NEWBORN; NICK END LABELING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENETICS; MALE; METABOLISM; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TUNEL ASSAY;

ANIMALS; APOPTOSIS; CALCIUM CHANNEL BLOCKERS; CASPASE 12; CASPASE 3; CELLS, CULTURED; DIHYDROPYRIDINES; IN SITU NICK-END LABELING; MALE; MYOCYTES, CARDIAC; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908067403     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.08.004     Document Type: Article

References (33)

1. Frangogiannis N.G. The inflammatory response inmyocardialinjury, repair, and remodelling. Nat Rev Cardiol 2014, 11:255-265.
2. Gruzdeva O., Uchasova E., Dyleva Y., Belik E., Shurygina E., et al. Insulin resistance and inflammation markers in myocardial infarction. J Inflamm Res 2013, 6:83-90.
3. Lin H., Li H.F., Lian W.S., Chen H.H., Lan Y.F., et al. Thromboxane A2 mediates iron-overload cardiomyopathy in mice through calcineurin-nuclear factor of activated T cells signaling pathway. Circ J 2013, 77:2586-2595.
4. Khimenko P.L., Bagby G.J., Fuseler J., Taylor A.E. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol 1998, 85:2005-2011.
5. Zhu J., Liu M., Kennedy R.H., Liu S.J. TNF-alpha-induced impairment of mitochondrial integrity and apoptosis mediated by caspase-8 in adult ventricular myocytes. Cytokine 2006, 34:96-105.
6. Shen M., Wu R.X., Zhao L., Li J., Guo H.T., et al. Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS One 2012, 7:e51223.
7. Takemura G., Kanoh M., Minatoguchi S., Fujiwara H. Cardiomyocyte apoptosis in the failing heart-a critical review from definition and classification of cell death. Int J Cardiol 2013, 167:2373-2386.
8. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999, 13:1899-1911.
9. Lomonosova E., Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008, 27(Suppl 1):S2-19.
10. Reed J.C. Bcl-2 family proteins. Oncogene 1998, 17:3225-3236.
11. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009, 43:67-93.
12. Whelan R.S., Kaplinskiy V., Kitsis R.N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 2010, 72:19-44.
13. Anacak G.Y., Ustunes L., Dilsiz O.Y., Ergul A. Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. Vascul Pharmacol 2010, 53:193-199.
14. Cristofori P., Lanzoni A., Gaviraghi G., Turton J., Sbarbati A. Anti-atherosclerotic activity of the calcium antagonist lacidipine in cholesterol-fed hamsters. Biomed Pharmacother 2000, 54:93-99.
15. Cagalinec M., Kyselovic J., Blaskova E., Bacharova L., Chorvat D., et al. Comparative study of the effects of lacidipine and enalapril on the left ventricular cardiomyocyte remodeling in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2006, 47:561-570.
16. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem J 1999, 344(Pt 2):281-292.
17. Michalak M., Milner R.E., Burns K., Opas M. Calreticulin. Biochem J 1992, 285(Pt 3):681-692.
18. Johnson S., Michalak M., Opas M., Eggleton P. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol 2001, 11:122-129.
19. Krause K.H., Michalak M. Calreticulin. Cell 1997, 88:439-443.
20. Holaska J.M., Black B.E., Love D.C., Hanover J.A., Leszyk J., et al. Calreticulin Is a receptor for nuclear export. J Cell Biol 2001, 152:127-140.
21. Yue T.L., Wang C., Gu J.L., Ma X.L., Kumar S., et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000, 86:692-699.
22. Palomer X., Alvarez-Guardia D., Rodriguez-Calvo R., Coll T., Laguna J.C., et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 2009, 81:703-712.
23. Depuydt B., van Loo G., Vandenabeele P., Declercq W. Induction of apoptosis by TNF receptor 2 in a T-cell hybridoma is FADD dependent and blocked by caspase-8 inhibitors. J Cell Sci 2005, 118:497-504.
24. Park J.K., Fiebeler A., Muller D.N., Mervaala E.M., Dechend R., et al. Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury. Hypertension 2002, 39:685-689.
25. Taddei S., Virdis A., Ghiadoni L., Sudano I., Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002, 62:265-284.
26. Huai Y., Wang H., Zhao L., Zhao L., Pei J. Lacidipine inhibits endoplasmic reticulum stress and myocardial remodeling induced by pressure overload in rat heart. Eur J Pharmacol 2013, 718:441-447.
27. Rabkin S.W., Kong J.Y. Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes. Eur J Pharmacol 2000, 388:209-217.
28. Weiss J.N., Korge P., Honda H.M., Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003, 93:292-301.
29. Hegedus Z., Czibula A., Kiss-Toth E. Tribbles: novel regulators of cell function; evolutionary aspects. Cell Mol Life Sci 2006, 63:1632-1641.
30. Petak I., Houghton J.A. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 2001, 7:95-106.
31. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998, 17:1675-1687.
32. Chen M., Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002, 7:313-319.
33. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999, 15:269-290.